Tag: prescription drugs
People are really confused. We’ve embarked on a host of studies about long-term care. One component of that effort is to assess the public’s understanding of how these costs are financed. A bunch of surveys over the last 10 years indicate that people are confused; most think that Medicare plays a major role. In fact,…
The drug companies want $26,500 per year for the newest Alzheimer’s drug; negotiations might take it to $20,000. The potential for full Food and Drug Administration approval of the new Biogen-Esai Alzheimer’s drug (Leqembi) means that Medicare may make the drug available to beneficiaries. The $26,500 annual price tag associated with Leqembi will wreak havoc wit…
